Candel Therapeutics, Inc.

Developing off-the-shelf viral immunotherapies to help the immune system fight solid tumors.

CADL | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 117 KENDRICK STREET, 2494 NEEDHAM
Website:: https://www.candeltx.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies to help patients fight cancer. The company's approach is designed to stimulate a patient's immune system to create a personalized, systemic, and long-lasting response against their specific tumor. This is achieved by using engineered viruses to induce immunogenic cell death at the injection site, effectively creating an "in situ vaccination." Candel's pipeline, which includes candidates like CAN-2409 and CAN-3110, is being evaluated in clinical trials for various solid tumors, such as prostate, brain, lung, and pancreatic cancers. The company aims to provide efficacious and well-tolerated treatments for patients across different disease stages.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Candel Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Candel Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Candel Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

	Company	Country	Ticker
$AMARIN CORP PLC\UK Logo$	AMARIN CORP PLC\UK Develops prescription therapies like Vascepa® to reduce cardiovascular risk for patients.	United States of America	AMRN
	AMGEN INC Biotech pioneer developing innovative human therapeutics for the world's toughest diseases.	United States of America	AMGN
	Amicogen, Inc. Biotech firm using enzyme tech for pharma, healthcare, and bioprocess CDMO services.	South Korea	092040
	AMICUS THERAPEUTICS, INC. Develops advanced therapies for rare lysosomal storage disorders.	United States of America	FOLD
	AMINOLOGICS CO.,LTD. Manufactures high-purity chiral amino acids & APIs for pharma, chemical, and food industries.	South Korea	074430
	Amneal Pharmaceuticals, Inc. Develops & commercializes essential medicines: generics, injectables & specialty drugs.	United States of America	AMRX
	Amphastar Pharmaceuticals, Inc. Develops and manufactures complex injectable, intranasal, and inhalation pharmaceutical products.	United States of America	AMPH
	Amylyx Pharmaceuticals, Inc. Developing novel therapies for neurodegenerative diseases like ALS and Wolfram syndrome.	United States of America	AMLX
	AN2 Therapeutics, Inc. Developing novel small molecule drugs for infectious diseases and oncology using boron chemistry.	United States of America	ANTX
	Ananda Pharma Plc Develops approved cannabinoid medicines for pain, epilepsy, and heart failure.	United Kingdom	ANAN